- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Riptide rebrands itself to reflect focus on future
Riptide rebrands itself to reflect focus on futureRiptide Technologies is changing its name to Avreo, a variant of the Greek “avrio” meaning “tomorrow.” The New Orleans-based firm made this move to emphasize its concentration
Riptide rebrands itself to reflect focus on future
Riptide Technologies is changing its name to Avreo, a variant of the Greek avrio meaning tomorrow. The New Orleans-based firm made this move to emphasize its concentration on developing data-management solutions based on emerging technologies. Avreo launched version 1.0 of its XML-based system ARIIS (advanced radiology image and information system) in October (HNN 9/20/00) and is currently gearing up for the RSNA meeting in November.
- Search Again
- Return To HNN Homepage
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
